Edition:
United States

Evolus Inc (EOLS.OQ)

EOLS.OQ on NASDAQ Stock Exchange Global Market

11.60USD
23 Feb 2018
Change (% chg)

$-0.49 (-4.05%)
Prev Close
$12.09
Open
$12.08
Day's High
$12.14
Day's Low
$11.59
Volume
38,531
Avg. Vol
--
52-wk High
$12.83
52-wk Low
$9.68

Chart for

About

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $273.68
Shares Outstanding(Mil.): 23.59
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 195.87 16.59
EPS (TTM): -- -- --
ROI: -- -0.71 35.07
ROE: -- -3.37 17.79

BRIEF-Evolus Announces Pricing Of Initial Public Offering Of Common Stock

* EVOLUS, INC. ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING OF COMMON STOCK

Feb 07 2018

BRIEF-Evolus Inc Sees IPO Priced To Be Between $12 And $14 Per Share

* EVOLUS INC SEES IPO OF 5 MILLION SHARES PRICED TO BE BETWEEN $12 AND $14 PER SHARE – SEC FILING‍​

Jan 29 2018

Earnings vs. Estimates

No consensus analysis data available.